- Home
- IZM vs PYPD Comparison
IZM vs PYPD Comparison
Compare IZM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- PYPD
- Stock Information
- Founded
- IZM 2011
- PYPD 2008
- Country
- IZM China
- PYPD Israel
- Employees
- IZM N/A
- PYPD N/A
- Industry
- IZM Consumer Electronics/Video Chains
- PYPD Medical/Dental Instruments
- Sector
- IZM Consumer Discretionary
- PYPD Health Care
- Exchange
- IZM Nasdaq
- PYPD Nasdaq
- Market Cap
- IZM 23.7M
- PYPD 19.4M
- IPO Year
- IZM 2023
- PYPD 2020
- Fundamental
- Price
- IZM $1.47
- PYPD $3.30
- Analyst Decision
- IZM
- PYPD Strong Buy
- Analyst Count
- IZM 0
- PYPD 2
- Target Price
- IZM N/A
- PYPD $10.50
- AVG Volume (30 Days)
- IZM 71.6K
- PYPD 49.0K
- Earning Date
- IZM 01-29-2025
- PYPD 02-12-2025
- Dividend Yield
- IZM N/A
- PYPD N/A
- EPS Growth
- IZM N/A
- PYPD N/A
- EPS
- IZM N/A
- PYPD N/A
- Revenue
- IZM $177,933,890.00
- PYPD N/A
- Revenue This Year
- IZM N/A
- PYPD N/A
- Revenue Next Year
- IZM N/A
- PYPD N/A
- P/E Ratio
- IZM N/A
- PYPD N/A
- Revenue Growth
- IZM N/A
- PYPD N/A
- 52 Week Low
- IZM $1.44
- PYPD $2.37
- 52 Week High
- IZM $52.21
- PYPD $7.00
- Technical
- Relative Strength Index (RSI)
- IZM 17.87
- PYPD 55.20
- Support Level
- IZM $1.50
- PYPD $2.93
- Resistance Level
- IZM $1.80
- PYPD $3.35
- Average True Range (ATR)
- IZM 0.10
- PYPD 0.24
- MACD
- IZM -0.02
- PYPD 0.04
- Stochastic Oscillator
- IZM 6.59
- PYPD 93.15
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.